We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.42%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$40.8B
AUM Growth
-$2.75B
(-6.3%)
Cap. Flow
-$4B
Cap. Flow
% of AUM
-9.79%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
1,449
New
354
Increased
347
Reduced
344
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$612M |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$454M |
| 3 |
BP
BP
|
+$442M |
| 4 |
TSMC
TSM
|
+$416M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$959M |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
UnitedHealth
UNH
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$508M |
| 5 |
Walt Disney
DIS
|
+$409M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.15% |
| 2 | Healthcare | 18.68% |
| 3 | Financials | 14.67% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Edwards Lifesciences
EW
$51.3B
| $62.8M | 0.15% |
1,294,581
+321,867
| +33% | +$15M |
|
152
Darden Restaurants
DRI
$23.8B
| $62.7M | 0.15% |
586,044
-38,409
| -6% | -$3.52M |
|
|
CLR
153
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $62.3M | 0.15% |
+961,971
| New | +$62.2M |
|
154
Fidelity National Information Services
FIS
$22.1B
| $61M | 0.15% |
575,040
-82,415
| -13% | -$8.39M |
|
155
Prudential Financial
PRU
$41.5B
| $60.5M | 0.15% |
646,851
-74,263
| -10% | -$7.5M |
|
156
Westlake Corp
WLK
$10.1B
| $57.8M | 0.14% |
537,295
-29,784
| -5% | -$3.34M |
|
157
Toronto Dominion Bank
TD
$200B
| $57.5M | 0.14% |
993,313
-6,264,515
| -86% | -$358M |
|
158
Northern Trust
NTRS
$33.7B
| $56.8M | 0.14% |
551,840
+162,990
| +42% | +$17.3M |
|
159
Southern Copper
SCCO
$164B
| $56.8M | 0.14% |
1,306,271
-613,638
| -32% | -$29.4M |
|
|
CDK
160
DELISTED
CDK Global, Inc.
CDK
| $55.9M | 0.14% |
859,361
+834,261
| +3,324% | +$53.9M |
|
161
Marriott International
MAR
$94.2B
| $55.7M | 0.14% |
440,196
-136,922
| -24% | -$18.6M |
|
162
Match Group
MTCH
$8.9B
| $55.6M | 0.14% |
+1,434,612
| New | +$60.2M |
|
163
ENI
E
$76.5B
| $55.2M | 0.14% |
1,486,020
+1,065,301
| +253% | +$40M |
|
164
Planet Fitness
PLNT
$4.48B
| $54.3M | 0.13% |
1,236,872
+46,412
| +4% | +$1.9M |
|
|
PTR
165
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $54.1M | 0.13% |
709,199
+241,302
| +52% | +$18.3M |
|
166
Maximus
MMS
$3.32B
| $53.7M | 0.13% |
864,230
-51,343
| -6% | -$3.33M |
|
167
AstraZeneca
AZN
$250B
| $53.4M | 0.13% |
759,917
+726,012
| +2,141% | +$52.2M |
|
168
Xylem
XYL
$28.5B
| $53.1M | 0.13% |
788,772
-246,073
| -24% | -$17.9M |
|
169
FirstCash
FCFS
$9.02B
| $52.4M | 0.13% |
583,670
+488,344
| +512% | +$43.2M |
|
170
Novartis
NVS
$294B
| $52.1M | 0.13% |
769,705
+454,742
| +144% | +$31.4M |
|
171
Cintas
CTAS
$80.6B
| $51.9M | 0.13% |
1,122,240
+1,099,840
| +4,910% | +$49.5M |
|
172
Amdocs
DOX
$5.87B
| $51.9M | 0.13% |
783,415
+278,854
| +55% | +$18.8M |
|
173
STMicroelectronics
STM
$47.1B
| $51.4M | 0.13% |
2,322,701
-47,775
| -2% | -$1.11M |
|
174
Brown-Forman Class B
BF.B
$13B
| $49.9M | 0.12% |
+1,018,938
| New | +$55.8M |
|
175
Hilton Grand Vacations
HGV
$3.66B
| $49.5M | 0.12% |
1,427,426
+337,970
| +31% | +$13.7M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Arrowstreet Capital held 1,449 positions worth $40.8B, down 6.3% from $43.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital withdrew a net $4B in Q2 2018, closing 396 positions and reducing 344 holdings. Its most notable exit was Applied Materials, an estimated $508M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Arrowstreet Capital opened a new position in Stellantis worth $85.1M.
- Arrowstreet Capital's largest Q2 2018 buy was Stellantis: 4,458,651 shares worth $85.1M.
- Arrowstreet Capital added most to Microsoft in Q2 2018, an estimated $612M increase.
- Arrowstreet Capital's biggest Q2 2018 reduction was Boeing, cutting an estimated $959M.
- Arrowstreet Capital fully exited Applied Materials in Q2 2018, selling an estimated $508M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $40.8B portfolio in Q2 2018.
- Arrowstreet Capital opened 354 new positions and closed 396 in Q2 2018.
- Arrowstreet Capital's portfolio value fell 6.3% quarter-over-quarter to $40.8B.
Based on Arrowstreet Capital's 13F filing for Q2 2018, filed 14 Aug 2018.